Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.65
Bid: 1.60
Ask: 1.70
Change: -0.175 (-9.59%)
Spread: 0.10 (6.25%)
Open: 1.825
High: 1.825
Low: 1.65
Prev. Close: 1.825
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: UBS down 15%, Credit Suisse down 60% after deal

Mon, 20th Mar 2023 08:53

(Alliance News) - Stock prices in London opened lower on Monday morning as the emergency takeover of beleaguered lender Credit Suisse over the weekend failed to quell market turmoil.

"It is not yet known exactly where more pain will emerge in the banking sector, but investors fear the problems are not yet over," said Susannah Streeter, head of money and markets at Hargreaves Lansdown.

The FTSE 100 index opened down 115.03 points, 1.6%, at 7,220.37. The FTSE 250 was down 405.08 points, or 2.2%, at 18,065.75, and the AIM All-Share was down 9.52 points, or 1.2%, at 794.51.

The Cboe UK 100 was down 1.5% at 722.97, the Cboe UK 250 was down 2.1% at 15,697.40, and the Cboe Small Companies was down 1.6% at 12,644.51.

UBS will take over its troubled Swiss rival Credit Suisse for USD3.25 billion following crunch talks on Sunday aimed at stopping the stricken bank from triggering a wider international banking crisis.

The Swiss government said the deal, involving Switzerland's biggest bank taking over the second-largest, was vital to prevent irreparable economic turmoil spreading throughout the country and beyond.

Michael Hewson, chief market analyst at CMC Markets, said: "Some have suggested that UBS putting such a low-ball number on its interest means that Credit Suisse could be in more trouble than perhaps regulators are letting on, and while that might be true, it could also be UBS management being extremely cautious."

Shares in UBS were 15% lower in Zurich on Monday morning. The bank has a market capitalisation of CHF53.17 billion. Shares in Credit Suisse plunged 63% for a market cap of just CHF2.78 billion, about USD2.99 billion.

The acquisition was welcomed in Washington, Brussels and London as one that would support financial stability.

The Bank of England has insisted the financial system in the UK remains "safe and sound", in an effort to calm fears after the emergency sale.

The pound was quoted at USD1.2170 at early on Monday in London, virtually unchanged compared to USD1.2168 at the London equities close on Friday.

In European equities on Monday, the CAC 40 in Paris was down 0.8%, while the DAX 40 in Frankfurt was down 1.0%.

France's central bank chief sought to distance European and French banks from the problems at Credit Suisse and banking woes in the US.

Credit Suisse and the banking volatility in the US "don't concern French and European banks", Francois Villeroy de Galhau, a member of the European Central Bank's governing council, told France Inter radio.

The euro stood at USD1.0636, lower from USD1.0665 late Friday. Against the yen, the dollar was trading at JPY130.69, down from JPY132.12.

Francesco Pesole at ING said he expects the yen to stay in demand for now amid the current risk-off market backdrop.

The US Federal Reserve and other major central banks are making a coordinated effort to improve banks' access to liquidity. The special drive will be launched on Monday by the Fed and the central banks of Canada, the UK, Japan, the EU and Switzerland.

The move comes after the US banking regulator struck a deal to sell most of the assets of the failed Signature Bank to another institution on Sunday.

Signature Bank was seized by the Federal Deposit Insurance Corp a week ago after it imploded in the wake of the collapse of Silicon Valley Bank earlier in March. The FDIC is seeking a similar deal to sell off parts of SVB, according to Bloomberg.

Ipek Ozkardeskaya, senior analyst at Swissquote Bank, said: "The next few hours of trading will give us a better picture on whether the crisis is contained."

In London, banking stocks were the worst performers in early morning trade. Barclays was down 7.4%, Standard Chartered down 8.0%, NatWest down 7.8%, and Lloyds down 4.6%. HSBC, which last week bought the UK arm of SVB, was 5.1% lower.

Conversely, mining stocks were some of Monday's top performers, with Fresnillo up 3.3% and Endeavour Mining up 6.2%.

Separately, the UK water services regulation authority Ofwat on Monday announced new powers that will enable it to stop the payment of dividends by water utilities if they would "risk the company's financial resilience". It said it would also take enforcement action against water companies that don't link dividend payments to performance.

Ofwat said the change will require company board to "take account of their performance" for customers and the environment when deciding to make dividend payments and will require companies to "maintain a higher level of overall financial health".

Water utilities were higher in early morning trade, with investors perhaps fearing worse from the regulator amid growing political pressure following the repeated release of sewage into UK rivers. United Utilities was up 1.2%, Severn Trent up 1.3%, and Pennon up 0.3%.

Elsewhere in the FTSE 100, Intertek was down 0.4%. The product testing, inspecting and certification firm announced the promotion of Colm Deasy to chief financial officer.

Deasy replaces Jonathan Timmis who has stepped down with immediate effect, with no reason provided by the company for his departure.

In the FTSE 250, FirstGroup fell 1.4% despite announcing it extended the current arrangements for its West Coast partnership rail contract with the UK Department for Transport.

The arrangements were set to expire on March 31 and have now been extended to October 15, "broadly" under the same terms and conditions, the public transport provider said.

The contract comprises of the operation of Avanti West Coast and the shadow operation of the HS2 programme.

On AIM, Genedrive jumped 8.1% after it announced that its MT-RNR1 ID kit is in process for roll out at two further hospital sites in the Greater Manchester.

Genedrive's MT-RNR1 ID kit is a commercial point-of-care genetic test that helps to avoid irreversible lifelong hearing loss in specific infants exposed to aminoglycosides antibiotics by detecting a gene variant that can cause deafness, allowing for alternative antibiotics to be prescribed.

In Asia on Monday, the Japanese Nikkei 225 index closed down 1.4%. In China, the Shanghai Composite closed down 0.5%, while the Hang Seng index in Hong Kong finished down 2.7%. The S&P/ASX 200 in Sydney lost 1.4%.

China's central bank left its interest rates unchanged. The People's Bank of China said it held its one-year loan prime rate - which serves as a benchmark for corporate loans - at 3.65%. The five-year rate also remained at 4.3%.

It was the seventh successive month that the PBoC left rates unchanged. The move had been anticipated by the market, according to FXStreet-cited consensus.

In the US on Friday, Wall Street ended lower, with the Dow Jones Industrial Average down 1.2%, the S&P 500 down 1.1% and the Nasdaq Composite down 0.7%.

Brent oil was quoted at USD70.26 a barrel early in London on Monday, down from USD73.43 late Friday. Gold was quoted at USD2,004.05 an ounce, sharply higher against USD1,957.76.

Naeem Aslam, chief investment officer at Zaye Capital Markets, said the yellow metal remains in demand because investors believe that banks are not out of the woods yet.

"Traders always prefer safe haven in a situation like this as the contagion risk is always very high," Aslam said.

Still to come in Monday's economic calendar, there is a US retail trade report at 1400 GMT.

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
2 Jan 2024 10:57

IN BRIEF: Genedrive draws down GBP600,000 on prepayment facility

Genedrive PLC - Manchester, England-based molecular diagnostics company - Draws down GBP600,000 on its GBP5 million equity prepayment facility. In March last year, Genedrive agreed the GBP5 million equity prepayment facility with Riverfort Global Opportunities PCC Ltd. At the time it said that proceeds would be used towards the commercialisation of the antibiotic-induced hearing loss test, Genedrive MT-RNR1 ID Kit, and enhancing the Genedrive platform as well as providing additional working capital.

Read more
22 Dec 2023 15:50

UK shareholder meetings calendar - next 7 days

Monday 25 December 
no events scheduled 
Tuesday 26 December 
no events scheduled 
Wednesday 27 December 
Tremor International LtdAGM
Thursday 28 December 
ADVFN PLCAGM
Altona Rare Earths PLCAGM
Beximco Pharmaceuticals LtdAGM
Global Petroleum LtdAGM
Visum Technologies PLCAGM
Friday 29 December 
Apollon Formularies PLCAGM
Eco Atlantic Oil & Gas LtdAGM
Genedrive PLCAGM
Goldplat PLCAGM
Lansdowne Oil & Gas PLCGM re capital raise
Marula Mining PLCAGM
Microsaic Systems PLCGM re fundraise
Online Blockchain PLCAGM
Secure Property Development & Investment PLCAGM
SkinBioTherapeutics PLCAGM
Tetragon Financial Group LtdAGM
Woodbois LtdAGM
Zambeef Products PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
20 Dec 2023 13:57

Genedrive gets first product orders from several countries

(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive has received its first orders for Genedrive MT-RNR1 products from several countries, it announced on Wednesday, including France, Austria, Greece, Saudi Arabia, Turkey, and the Netherlands.

Read more
20 Dec 2023 11:07

AIM WINNERS & LOSERS: Genedrive shares jump on orders

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
20 Dec 2023 10:49

IN BRIEF: Genedrive shares surge as six countries receive first orders

Genedrive PLC - Manchester, England-based molecular diagnostics company - Says initial orders of its MT-RNR1 products from France, Austria, the Netherlands, Greece, Saudi Arabia and Turkey have been received. News follows confirmation that commercial distribution agreements were signed in multiple countries for Genedrive's test for antibiotic induced hearing loss. Genedrive says these initial orders will support its international distribution partners in promotion and in-country evaluation activities in their respective countries. Hopes this will "provide more extensive access to this life-changing test."

Read more
4 Dec 2023 17:33

TRADING UPDATES: 600 Group disposal and funding talks continue

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
30 Nov 2023 10:03

Genedrive shares fall as annual loss widens but focused on investing

(Alliance News) - Genedrive PLC on Thursday reported a widened loss but said it remains focused on investing in product development, focusing on maximising the benefits of its platform.

Read more
29 Nov 2023 21:36

EARNINGS AND TRADING: Southern Energy loss swing; Craven House widens

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
23 Nov 2023 15:54

UK earnings, trading statements calendar - next 7 days

Friday 24 November 
no events scheduled 
Monday 27 November 
Celebrus Technologies PLCHalf Year Results
DSW Capital PLCHalf Year Results
JLEN Environmental Assets Group LtdHalf Year Results
Northern Bear PLCHalf Year Results
Rightmove PLCTrading Statement
Serinus Energy PLCQ3 Results
SysGroup PLCHalf Year Results
Tuesday 28 November 
Altitude Group PLCHalf Year Results
Augmentum FintechHalf Year Results
Brickability Group PLCHalf Year Results
DP Eurasia NVTrading Statement
easyJet PLCFull Year Results
Focusrite PLCFull Year Results
Greencore Group PLCFull Year Results
IG Design Group PLCHalf Year Results
Kinovo PLCHalf Year Results
Loungers PLCHalf Year Results
Mercia Asset Management PLCHalf Year Results
Pets At Home Group PLCHalf Year Results
Renew Holdings PLCFull Year Results
Safestore Holdings PLCTrading Statement
Supreme PLCHalf Year Results
Topps Tiles PLCFull Year Results
Treatt PLCFull Year Results
Vp PLCHalf Year Results
Wednesday 29 November 
Amaroq Minerals LtdQ3 Results
Benchmark Holdings PLCFull Year Results
Braemar PLCHalf Year Results
Cordiant Digital Infrastructure LtdHalf Year Results
CVS Group PLCTrading Statement
Halfords Group PLCHalf Year Results
Harbour Energy PLCTrading Statement
Pennon Group PLCHalf Year Results
Vinanz LtdQ3 Results
Thursday 30 November 
Carclo PLCHalf Year Results
Dr Martens PLCHalf Year Results
Genedrive PLCFull Year Results
James Latham PLCHalf Year Results
LXi REIT PLCHalf Year Results
ME Group International PLCTrading Statement
TClarke PLCTrading Statement
Tharisa PLCFull Year Results
Walker Crips Group PLCHalf Year Results
Zoo Digital Group PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
28 Sep 2023 16:09

IN BRIEF: Genedrive to receive GBP1.2 million grant for test kit

Genedrive PLC - Manchester-based molecular diagnostics company - Confirms that it expects to benefit from GBP1.2 million of funding, through its participation in a multi-partner grant award from Innovate UK and the UK government Innovation Accelerator programme. The grant, which is for the development and validation of technology for time critical genomic testing, will provide Genedrive with acute care patient access and supporting infrastructure to assess the real world clinical performance of time-critical clinical tests in NHS settings.

Read more
11 Sep 2023 15:21

Genedrive appoints new chief executive and chief scientific officer

(Alliance News) - Genedrive PLC on Monday said it appointed James Cheek as its new chief executive officer, effective immediately.

Read more
6 Sep 2023 13:55

Genedrive diagnostic test system gets UKCA registration

(Sharecast News) - Point-of-care molecular diagnostics developer Genedrive announced on Wednesday that its Genedrive CYP2C19 System has received UKCA marking registration.

Read more
6 Sep 2023 11:18

Genedrive shares jump as hails UKCA mark for test; aims for EU CE mark

(Alliance News) - Genedrive PLC on Wednesday said that its CYP2C19 point of care test achieved marking registration in the UK, known as UKCA.

Read more
5 Jul 2023 15:30

TRADING UPDATES: RTW plans buyback; Octopus AIM VCTs eye fundraise

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
5 Jul 2023 14:41

Genedrive draws down £0.3m under equity prepayment facility

(Sharecast News) - Molecular diagnostics company Genedrive announced the latest drawdown of £0.3m under its £5m equity prepayment facility on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.